Latest news with #Calzadilla
Yahoo
28-05-2025
- Business
- Yahoo
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL. Adaptive Biotechnologies' management is scheduled to participate in a fireside chat on Wednesday, June 11th at 5:40 a.m. Pacific Time / 8:40 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the 'Investors' section of the company website at: About Adaptive Biotechnologies Adaptive Biotechnologies ('we' or 'our') is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. ADAPTIVE INVESTORSKarina Calzadilla, Vice President, Investor Relations and FP&A201-396-1687investors@ ADAPTIVE MEDIAErica Jones, Associate Corporate Communications Director206-279-2423media@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
03-05-2025
- Automotive
- CBS News
Formula 1 fans stranded, their vehicles towed after paying group to park near Hard Rock Stadium for Miami Grand Prix
Several Formula 1 fans found themselves stranded near the Miami Grand Prix at Hard Rock Stadium in Miami Gardens on Friday evening. They paid to park in a lot across the street, but hours later, they found their cars, trucks and SUVs missing, along with the people who took payment. "We're all like, 'How did our cars get towed?'" said Johnathan Martinez of Hialeah. "Did we just get scammed? Were those people pretending to be that?" Andres Escobar came from Ecuador with two friends. They rented a car and steered themselves into trouble. "We came to this list to park and a woman with a [parking company] logo on her shirt told us to pay [$60]," Escobar said. It seemed legitimate, he said. So Escobar and others paid via Zelle. Mauro Calzadilla, who carpooled with Martinez, saw the same lot used by customers for other events at the stadium in the past and never heard about problems. Initially, he planned to park in the Walmart lot closer to the stadium. However, the parking attendant charged $100 per vehicle, Calzadilla said. So he parked near Escobar and the attendant gave drivers receipts to leave on their dashboard. When F1 fans left the stadium around 5 p.m., people found their parking spaces empty. "My [truck] got towed," Calzadilla said. "[It was] not just me. There were literally like eight cars that got towed there easily." Martinez and Calzadilla called the number attached to the Zelle account that took payment, the men said. The person who answered blamed a dispute over money with the property's landlord, Martinez said. CBS News Miami called the landlord, but no one answered and the voicemail box was full. "We have like 18 people here who are all stranded because we have no cars," Martinez said. The group turned to Miami-Dade County Sheriff's deputies standing nearby, who suggested people complain to Miami Gardens Police, Calzadilla said. Some did, yet all felt they had no choice but the find rides to the tow lot and pay to get their rides back.
Yahoo
05-02-2025
- Business
- Yahoo
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ('Adaptive Biotechnologies') (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences. BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UTParticipating on Wednesday, February 12, 2025 TD Cowen 45th Annual Health Care Conference in Boston, MAFireside chat on Monday, March 3, 2025, at 11:10 a.m. Eastern Time Interested parties may access live and archived webcasts of the session on the 'Investors' section of the company website at: About Adaptive Biotechnologies Adaptive Biotechnologies ('we' or 'our') is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. ADAPTIVE INVESTORSKarina Calzadilla, Vice President, Investor Relations and FP&A201-396-1687investors@ ADAPTIVE MEDIAErica Jones, Associate Corporate Communications Director206-279-2423media@
